Optimization of nutritional strategies using a mechanistic computational model in prediabetes: Application to the J-DOIT1 study data

PLoS One. 2023 Nov 30;18(11):e0287069. doi: 10.1371/journal.pone.0287069. eCollection 2023.

Abstract

Lifestyle interventions have been shown to prevent or delay the onset of diabetes; however, inter-individual variability in responses to such interventions makes lifestyle recommendations challenging. We analyzed the Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1) study data using a previously published mechanistic simulation model of type 2 diabetes onset and progression to understand the causes of inter-individual variability and to optimize dietary intervention strategies at an individual level. J-DOIT1, a large-scale lifestyle intervention study, involved 2607 subjects with a 4.2-year median follow-up period. We selected 112 individuals from the J-DOIT1 study and calibrated the mechanistic model to each participant's body weight and HbA1c time courses. We evaluated the relationship of physiological (e.g., insulin sensitivity) and lifestyle (e.g., dietary intake) parameters with variability in outcome. Finally, we used simulation analyses to predict individually optimized diets for weight reduction. The model predicted individual body weight and HbA1c time courses with a mean (±SD) prediction error of 1.0 kg (±1.2) and 0.14% (±0.18), respectively. Individuals with the most and least improved biomarkers showed no significant differences in model-estimated energy balance. A wide range of weight changes was observed for similar model-estimated caloric changes, indicating that caloric balance alone may not be a good predictor of body weight. The model suggests that a set of optimal diets exists to achieve a defined weight reduction, and this set of diets is unique to each individual. Our diabetes model can simulate changes in body weight and glycemic control as a result of lifestyle interventions. Moreover, this model could help dieticians and physicians to optimize personalized nutritional strategies according to their patients' goals.

MeSH terms

  • Body Weight
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2* / etiology
  • Diabetes Mellitus, Type 2* / prevention & control
  • Glycated Hemoglobin
  • Humans
  • Japan
  • Prediabetic State* / complications
  • Prediabetic State* / therapy
  • Weight Loss

Substances

  • Glycated Hemoglobin

Grants and funding

This work was supported by JSPS KAKENHI Grant Number 18k01988.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PricewaterhouseCoopers, LLP provided support in the form of salaries for the following authors - [JHC, MF, SP, PMD, SPV, GD] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.